Rafael Canton is a Reporter at PE Hub. He covers private equity and has a diverse background in business and economics, with a focus on finance, investment, and sports, particularly basketball and football. Rafael's work has been featured in prominent outlets including Adweek, ONE37pm, SNY, and Yahoo Sports.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
New York, United States (Local)
Not enough data
Rafael's coverage heavily focuses on sports, particularly basketball, and private equity within the United States. His articles feature insights into player analysis, private equity involvement in sports franchises, and other related events.
Given Rafael’s focus on these topics, he may be open to pitches involving exclusive interviews or expert commentary from individuals deeply involved in the world of basketball or those with insights into the intersection of private equity and sports.
As his geographic focus is New York-based but not exclusive to this region, consider tailoring your pitch to include relevant ties to New York when applicable while still ensuring broader appeal.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Rafael Canton
rafael canton The first quarter of the 2024-25 Knicks regular season has been a bit of a feel out period.
By: Rafael Canton
'What differentiates the NFL from the other leagues is higher revenues, higher valuations and cashflow,' says Park Lane's Sean Clemens.
By: Rafael Canton
Private equity was bullish about sports in 2024. Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight.
rafael canton The Knicks' bench is very thin this season.
By: Rafael Canton
Blackstone is 'positioning itself to be the largest financial investor in AI infrastructure in the world,' said Stephen Schwarzman.
By: Rafael Canton
Private equity bets on data centers. Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight.
By: Rafael Canton
Xerox agreed to acquire Lexmark for $1.5 billion. Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight.
rafael canton After playing their 28th game on Saturday night, the Knicks have completed the first trimester of the 82-game season.
By: Francisco Javier Candel, Miguel Salavert, Rafael Cantón, José Luis, Fátima Galán-Sánchez, David Navarro, Alejandro Rodríguez, Juan Carlos Rodríguez, Montserrat Rodríguez-Aguirregabiria, Borja Suberviola, Rafael Zaragoza
Rapid multiplex molecular syndromic panels (RMMSP) (3 or more pathogens and time-to-results < 6 h) allow simultaneous detection of multiple pathogens and genotypic resistance markers. Their implementation has revolutionized the clinical landscape by significantly enhancing diagnostic accuracy and reducing time-to-results in different critical conditions. The current revision is a comprehensive but not systematic review of the literature. We conducted electronic searches of the PubMed, Medline, Embase, and Google Scholar databases to identify studies assessing the clinical performance of RMMSP in critically ill patients until July 30, 2024. A multidisciplinary group of 11 Spanish specialists developed clinical questions pertaining to the indications and limitations of these diagnostic tools in daily practice in different clinical scenarios. The topics covered included pneumonia, sepsis/septic shock, candidemia, meningitis/encephalitis, and off-label uses of these RMMSP. These tools reduced the time-to-diagnosis (and therefore the time-to-appropriate treatment), reduced inappropriate empiric treatment and the length of antibiotic therapy (which has a positive impact on antimicrobial stewardship and might be associated with lower in-hospital mortality), may reduce the length of hospital stay, which could potentially lead to cost savings. Despite their advantages, these RMMSP have limitations that should be known, including limited availability, missed diagnoses if the causative agent or resistance determinants are not included in the panel, false positives, and codetections. Overall, the implementation of RMMSP represents a significant advancement in infectious disease diagnostics, enabling more precise and timely interventions. This document addresses relevant issues related to the use of RMMSP on different critically ill patient profiles, to standardize procedures, assist in making management decisions and help specialists to obtain optimal outcomes.
rafael canton The New York Knicks are a team built on consistency. We know Mikal Bridges is going to play every game and get to his patented fadeaway jumper in the lane.
(833) 317-6278 
